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Differential effects of depleting agents on cytoplasmic and nuclear
non-protein sulphydryls: a fluorescence image cytometry study
M Thomas*, T Nicklee and DW Hedley
C)vtometrv Interface Laboratory, Department ofOncologic Pathologv, Ontario Cancer Institute Princess Margaret Hospitalt
Toronto, Ontario M4X IK9. Canada.
Smar-, The intracellular distribution of glutathione (GSH) was measured by a quantitative image
cvtometry method, using the sulphydryl-reactive agent mercury orange. This readily forms fluorescent adducts
with GSH and other non-protein sulphydryls (NPSH), but reacts much more slowly with protein sulphydryls.
Under optimum staining conditions mean integrated mercury orange fluorescence per cell was closely cor-
related witb a standard biochemical assay for GSH. Use of the DNA dye DAPI as a counterstain allowed
measurement of nuclear NPSH. The mean nuclear-cytoplasmic ratio was 0.57±0.05. Isolation of nuclei under
aqueous conditions resulted in the loss of approximately 90 of mercury orange fluorescence, compared with
nuclear fluorescence from intact cells, suggesting that background labelling of protein sulphydryls or other
macromolecules is low. Depletion of GSH with NV-ethylmaleimide or diethylnaleate decreased mercury orange
fluorescence in the nucleus and cytoplasm to a similar extent. In contrast, mercury orange fluorescence in the
nucleus was much more resistant to DL-buthionine-S.R-sulphoximine (BSO) depletion than that in the
cytoplasm. This finding is compatible wvith a distinct pool of GSH in the nucleus that is comparatively
resistant to BSO depletion. Alternatively, the retention of fluorescence in the nucleus following GSH depletion
by BSO treatment might be due to accumulation of cysteine. These findings have implications for cancer
treatment since the level of NPSH in the nucleus might be a more important determinant of resistance to
DNA-damaging agents than that in cytoplasm. The image cytometry method described here is quantitative,
allows a measure of tumour cell heterogeneity and can be applied to small biopsy samples obtained by
fine-needle aspiration. Thus it appears suitable for prospective clinical studies in cancer patients, and for
monitoring the effects of GSH-depleting agents used as adjuncts to cancer chemotherapy or radiotherapy.
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Glutathione (GSH) plays a key role in the protection of
mammalian cells from ionising radiation and anti-cancer
drugs (Biaglow et al., 1983; Astor, 1984; Revesz, 1985; An-
drews et al., 1988; Hansson et al., 1988; Dusre et al., 1989).
GSH protects the cell (1) by reacting chemically with int-
racellular targets (mainly DNA), (2) by enzymatically reduc-
ing peroxides, (3) by enzymatically detoxifying electrophiles
and (4) by maintaining the redox state of cellular thiols. The
level of cellular GSH, either constitutive or following
biochemical manipulation, has been correlated with the
relative susceptibility and resistance of tumour cells to ionis-
ing radiation and a variety of anti-tumour agents (Arrich and
Nathan, 1984; Hamilton et al.. 1986; Russo et al., 1986;
Mistry and Harrap, 1991). In tissue culture GSH is usually
considered to be the dominant non-protein sulphydryl
(NPSH) involved in drug and radiation resistance. Although
cysteine is a more chemically reactive NPSH. it is usually
present at much lower concentrations than GSH.
There is good evidence that subcellular GSH pools exist in
cytosol and mitochondria, each with different rates of turn-
over and depletion (Jocelyn and Cronshaw, 1985; Reed,
1990). In order to protect the nuclear structures from damage
(Sandstrom and Marklund 1990) and to participate to DNA
synthesis (Thelander and Reichard, 1979), GSH must also be
present in the nucleoplasm, but little is known about the
nuclear GSH content, and the published values for the
nuclear-cytoplasmic distribution of GSH vary according to
the techniques used (Edgren and Revesz, 1987; Tirmenstein
and Reed, 1988; Britten et al., 1991; Jevtovic-Todorovic and
Guenthner, 1992). Taylor et al. (1973) found that subcellular
fractionation of rat liver by aqueous techniques gave nuclei
which contained little or no GSH. while in contrast Tirmens-
ten and Reed (1988) reported that fractionation of rat kidney
under non-aqueous conditions gave values for nuclear GSH
which were similar to those in the cytoplasm. Other frac-
tionation techniques have provided equivocal results
(Tirmenstein and Reed, 1988; Britten et al.. 1991; Jevtovic-
Todorovic and Guenthner, 1992). Recently, Bellomo et al.
(1992) carried out a study, intended to measure the intracel-
lular distribution of GSH in intact hepatocytes, using the
non-fluorescent probe monochlorobimane, which permeates
cells and produces a strongly fluorescent bimane-glutathione
conjugate under the action of glutathione S-transferase
(Hulbert and Yakuba, 1983). Although they reported that
fluorescence was preferentially localised in the nucleus, with a
nuclear-cytoplasmic GSH ratio of about 3:1, Briviba et al.
(1993) have subsequently shown that a major drawback of
monochlorobimane is the ability of the GSH-bimane con-
jugate to diffuse from the cytoplasm to the nucleus. where it
is concentrated.
The sulphydryl-reactive dye mercury orange has been
shown to bind much more rapidly to GSH than to protein
thiols, and can therefore be used for the histochemical
localisation of GSH (Asghar et al.. 1975). Larrauri et al.
(1987) have adapted this procedure for measuring GSH in
cells cultured on plastic, and shown that the reaction product
between GSH and mercury orange precipitated inside the cell
with no appreciable diffusion into the supematant. We have
now modified this method by using fluorescence image
cytometry to allow quantification of GSH in the whole cell
and nucleus, and have found evidence for the existence of a
distinct pool of GSH in the cell nucleus which is resistant to
depletion by buthionine sulphoximine. an inhibitor of de
novo synthesis.
Materials and methods
Cell lines and sample preparation
All cell lines used were grown in 25 cm3 Corning flasks in a
humidified 5% carbon dioxide/air incubator at 37C. Mouse
mammary carcinosarcoma EMT-6 cells were grown as a
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monolayer culture in a-minium essential medium (a-MEM)
supplemented with 5% fetal bovine serum (FBS) (PA
Biologials, Sydney, Australia). Chinese hamster ovary cells
were maintained as spinner cultures in cz-MEM supplemented
with 5% FBS. The human breast cancer cell line MCF-7 and
the mouse lung fibrosarcoma cell line KHT-c were grown in
ax-MEM supplemented with 10% FBS and the rat mammary
carcinoma Mat B in a-MEM supplemented with 10% FBS,
1% L-glutamine 200 mM (Gibco BRL, Grand Island, NY,
USA) and 1% hypoxanthine (Gibco). Cells were used during
the exponential phase of growth.
Cells were removed from the monolayer using 0.05% tryp-
sin and 0.53 mM EDTA (Gibco) for 5 min at 37C and
resuspended in a-MEM supplemented with 5% or 10% of
FBS at a final concentration of 1 x 10' cells ml-'. Slide
preparations were prepared using a cytocentrifu (Cytospin
3, Shandon Elliot, Astmoor, UK), a total of 7500 cells being
spread on each slide. Slides were airdried for at least 3 h to
evaporate all intracellular water, wrapped and kept at
- 70C. Before mercury orange staining the slides were
thawed for 1 h and unwrapped.
Staining with mercwy orange
Mercury orange [1(4-chloromercuryphenyl-azo-2-naphthol);
Sigma, St. Louis, MO, USA)] was first dissolved in acetone
and later brought to the concentration required in 9:1 (v/v)
acetone-water and kept at 4C. The staining solution was
added to slides in Coplin jars and allowed to stain for
different times at 4-C. The staining solution was then
removed and the slides were thoroughly washed with
acetone-water (9:1, v/v) for 5 min to remove excess staining
solution and then washed twice for 5 min with distilled water
and allowed to air dry for lOmin.
Slides were counterstained with the DNA-specific dye 4,6-
diamidino-2-phenylindole (DAPI, Sigma) at 1 Mzgml-' for
5 min at 4C, then rinsed twice for 5 min in phosphate-
buffered salaine (PBS) to remove background fluorescence.
Finally, the slides were mounted with a solution of 9:1
glycerol-PBS containing 0.23% 1,4-diazabicyclo [2.2.2.]
octane (Sigma), an antifading compound (Johnson et al.,
1982). Slides were immediately analysed or kept at 4-C for
less than 1 week before being analysed. Autofluorescence of
the cells was estimated by treating slides as mentioned above
but omitting the mercury orange from the staining solution.
Quantitativefluorescence microscopy
This was done using a SAMBA 4000 image cytometer (IPI,
Chantilly, VA, USA). The system consists of a reflected
fluorescence microscope (BX50, Olympus) fitted with a
100 W mercury arc lamp, connected to an intensified charge-
coupled device (CCD) camera (XC 77, Hamamastu, Japan),
a preprocessor (Matrox Mip), an image analysis processor
and a host computer (Victor 386). The hardware and soft-
ware packages of the system have already been described
elsewhere (Brugal, 1984).
Each fluorescent image was obtained through a x 40, NA
0.75 dry objective and digitised into a 512 x 480 image frame
onto 256 levels. For mercury orange fluorescence, cells were
excited at 530-560 nm and the images were obtained by
using a 570 nm dichroic mirror and a 590rm long-pass
barrier filter. For DAPI fluorescence, the excitation wave-
length was 360-370 um and images were acquired by using a
400 nm dichroic mirror and a 420 um long-pass barrier filter.
Image analysis involved acquisition of the background sig-
nal of the cell preparation in order to correct for possible
non-specific fluorescence for each fluorochrome, and the
interactive adjustment of the thresholds for cell selection and
segmentation. Image cytometry was carried out on 30-40
cells per slide as follows. The cells were first examined with
ultraviolet light and a digitised image of the nucleus as
defined by DAPI fluorescence recorded. The same field was
then examined with green light and a digitised image of
mercury orange fluorescence recorded for the whole cell.
Using an image analysis program, the integrated fluorescence
was derived for the entire cell using mercury orange and for
the nuclear area defined by DAPI staining, and the cytoplas-
mic GSH content obtained by subtraction.
Biochemical assay ofcellular glutathione
To determine the specificity and linearity of the fluorescence
image cytometry method a comparison was made with a
standard biochemical assay for GSH, using preparations
made from the same population of cells. This was based on
the glutathione reductase recycling method originally des-
cribed by Tietze (1969). The principle is the reduction by
GSH ofthe disulphide 5,5'-dithio-2-nitrobenzoic acid (DTNB),
yielding 2-nitro-5-thiobenzoic acid, which absorbs at 412 nm.
In the process GSH is oxidised, and the reaction is main-
tained by adding the enzyme glutathione reductase and the
eklctron donor NAPDH, so that the concentration of GSH is
rate limiting.
The cells were counted in a haemocytometer and I x 106
viable cells were resuspended in an Eppendorf tube in 0.5 ml
of cold 0.6% sulphosalicyclic acid (Sigma) made up in dis-
tilled water. They were left on ice for 1 h, then spun down at
14000 r.p.m. for 15 min at 4C. The supernatant was trans-
ferred to a new Eppendorf tube and stored at - 20-C. The
assay was a modification of that described by Eyer and
Podhradsky (1986). A 50p1 sample was diluted to 1 ml in
PBS containing 60pg of DTNB (Sigma), 200pg of NADPH
(Sigma), and 1 unit of glutathione reductase (Sigma). The
reaction rate was monitored using a spectrophotometer
(Cary, Varian Instruments), measuring absorption at 412 nm
over time. The GSH content of the sample was determined
by comparing the reaction rate with that obtained using a
series of known GSH concentrations.
Modification ofcellular glutathione content
In addition to comparing values for the image cytometry and
biochemical assays obtained for untreated cells, we inves-
tigated the effects of a variety of agents which deplete GSH
by different mechanisms. N-Ethylmalimide (NEM, Sigma)
chemically blocks -SH groups present in the cells, and was
used at a concentration of250pM for 30 min. Diethyhnaleate
(DEM, Sigma) is conjugated to GSH under the action of
GSH trawsferases, and is therefore more specific than NEM.
It was added to the monolayers at a final concentration of
100pM. Buthionine sulphoximine (BSO) is a potent and
specific inhibitor of -eglutamylcysteine synthetase, the rate-
limiting enzyme catalysing the first step of GSH biosynthesis,
and was used at a concentration of I mM for various times.
Resds
Measurement ofcellular GSH usig mercwy orange
Mercury orange staining produced a bright orange-red
fluorescence under excitation from the strong green emission
of the mercury arc lamp (Figure la), and the nuclear
indicator dye DAPI revealed the localisation of the nucleus
(Figure lb). A range of conditions was investigated in order
to ensure that staining of GSH was saturated while minimis
ing background labelling of protein sulphydryls. The
optimum stain concentration was found to be 75piM, made
up in 90% acetone, 10% water and used at 4-C, as described
by Larrauri et al., (1987) (Figure 2). The rate of reaction
with GSH and the specificity of staining were investigated
using cells which had been variably depleted of GSH by
treatment with BSO. As shown in Figure 3, GSH labelling
with mercury orange achieved saturation within 30 s, whereas
longer staining times resulted in increased background stain-
ing. Approximately 90% of this background was eliminated
by pretreatment of slides with 1 mM mercuric chloride, which
causes profound loss of all available reduced sulphydryls
(Treumer and Valet, 1986), indicating that it was substan-Nuclear GSH pool detection in intact cells
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Figure 1 Intracellular localisation of GSH in EMT-6 cells. (a)
Fluorescent image of the intracellular distribution of mercury
orange-GSH adducts. (b) Double exposure showing dual stain-
ing with mercury orange and the DNA dye DAPI (blue fluores-
cent; x 340).
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Figure 2 Relationship between mercury orange concentration
and the amount of final reaction product expressed as integrated
fluorescence per cell.
Figure 3 Effect of incubation time on the generation of
fluorescence in control cells (0) and cells treated with 1 mM BSO
for 24 h (0) stained with 75 jAM mercury orange for 1 min at 4°C.
Subtraction of these curves gives the time course for specific
labelling of GSH (inset).
tially due to binding of mercury orange to protein thiols. A
comparison of biochemically determined GSH content and
mean integrated mercury orange fluorescence obtained for
the same cell population is shown in Figure 4. There was a
strong, linear correlation between the two measurements oRer
a wide range of GSH values. The y-intercept, which
represents background mercury orange fluorescence when
biochemically determined GSH = 0, was comparatively low.
These results indicate that the image cytometry method is
capable of giving reliable estimates of cellular GSH content.
Measurement ofnuclear GSH
The nuclear-cytoplasmic ratio for mercury orange labelling
of non-GSH-depleted, intact EMT-6 cells ranged from 0.4 to
0.68 (mean = 0.57 ± 0.05). Nuclei were isolated from suspen-
sions of EMT-6 cells by hypotonic lysis. Approximately
5 x 105 cells were pelleted and 1 ml of hypotonic solution
(584 mg 1-' sodium chloride, 1000 mg 1- sodium citrate and
0.3 ml 1' Nonidet P40) added for 5 min at room
temperature. Cells were then centrifuged at 1000 r.p.m. for
5 min at 5°C, and an aliquot was stained with trypan blue to
confirm that the preparation was free from contamination
with intact cells. Slides were prepared and stained as for
whole EMT-6 cells. The integrated fluorescence recorded for
isolated nuclei was only 10.5% of the integrated fluorescence
for nuclei from whole cells. This suggests that the bulk of
nuclear fluorescence is derived from NPSH, rather than from
proteins or other macromolecules. The effects of GSH-
depleting agents on nuclear GSH were then investigated
under a range of conditions. As shown in Table I, depletion
of GSH by alkylation with NEM or by enzymatic conjuga-
tion to DEM markedly decreased GSH content measured by
mercury orange fluorescence, and for both agents the nuclear
and cytoplasmic GSH contents were depleted to a similar
extent. In contrast, incubation with BSO, which is a specific
inhibitor of de novo GSH synthesis and thus reduces the level
of GSH in a time-dependent manner, produced a much
greater rate of GSH depletion in cytoplasm than in the
nucleus (Figure 5). Exposure to 1 mM BSO resulted in 34%
depletion of the cytoplasmic mercury orange fluorescence at
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Table I Effects of NEM and DEM on the nuclear and cytoplasmic distribution of GSH
Treatment Nucleus Per cent control Cytoplasm Per cent control
Control 45917±4790 112941 17762
NEM (250pM)
30 min 12665 3086 27 23428 3228 20
DEM (0.I mM) 26603 2824 57 56600 3245 50
3h 11141 1068 24 29645±834 26
EMT-6 cells were incubated during the exponential phase ofthegrowth with the indicated agents and for
the indicated times. Cells were trypsinised and cytospin slides were prepared. Slides were then treated with
75tiM mercury orange in acetone-water (9:1. v v) for 1 miin, and the whole-cxel and nuclear fluorescence
measured. Cytoplasmic fluorescence was obtained by subtraction. Results are expressed as the mean
± s.e.m. of the measurements on three different experiments. NEM, N-ethyhnakimide; DEM, diethyl-
maleate.
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4 h. and 46% depletion after 24 h, whereas nuclear
fluorescence was not significantly depleted after 4 h, and
depletion at 24 h was only to 25% of the non-depleted
control.
Measurement ofcellular heterogeneity ofGSH content
Quantitative image cytometry allows an estimate of cellular
heterogeneity of whole-cell and nuclear GSH content of
human cancer biopsies. Figure 6 shows an example of a
locally advanced squamous cell carcinoma of cervix, disagg-
regated by collagenase treatment and processed as for the cell
lines. Malignant cells were identified by morphology. Area,
shown on the y-axis, was measured as the total area labelled
by mercury orange for the whole cell and as the area labelled
by DAPI for the nucleus, and converted into lLM2 using a
simple image-processing routine. Note that, despite the fact
that there is some correlation with cell size, there is con-
siderable heterogeneity in whole-cell and nuclear GSH con-
tent.
Discusso
GSH is a ubiquitous compound that is important in cellular
defence mechanisms against free radicals and reactive oxygen
species (Meister and Anderson, 1983). In experimental
Time (h)
Figue 5 GSH depletion from EMT-6 cell line by BSO. The cells
were exposed to 1 mM BSO and harvested at the times indicated.
The whole-cell (0) and nuclear (A) GSH content were
measured, and the cytoplasmic GSH content (0) was obtained
by subtraction.
models, increased cellular GSH or activity of GSH-dependent
enzymes can produce resistance to a wide range of cytotoxic
drugs, including alkylating agents, cisplatin and anthracyc-
lines, and under some circumstances to radiation therapy
(Barrancoa et al., 1990; Hosking et al., 1990). Furthermore,
experimental animal tumours show considerable
heterogeneity in GSH content (Shrieve et al., 1988; Lee et al.,
1989), and viable cell sorting following exposure to drugs or
radiation in vivo shows greater clonogemic survival in cells
with high GSH content (Lee and Sieman, 1989).
Heterogeneity of tumour cell GSH content is therefore likely
to be a factor determining drug resistance in vivo, although
no indication of this is obtained using standard bulk assays
such as the enzymatic technique (Tietze, 1969) or high-
performance liquid chromatography (Newton et al., 1981).
which give the mean value and are subject to error owing to
the variable admixture of stromal elements.
Agents which deplete GSH or inhibit GSH-dependent pro-
cesses have obvious potential as adjuncts to chemotherapy in
tumours which are drug resistant because of overexpression,
but this treatment strategy might increase toxicity to normal
tissues, which are also protected from cytotoxicity by GSH-
u -
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carcinoma.
dependent mechanisms, resulting in no overall therapeutic
gain. The rational use of GSH-modulating agents in the
clinic therefore requires a better understanding of the relative
imnportance of GSH in the protection of normal and malig-
nant cells. Compared with drug resistance based on the
P-glycoprotein efflux pump, there are surprisingly few studies
reporting the levels of GSH in human cancer biopsies, but in
general these suggest that GSH could be a significant factor
in man (Kudo et al., 1990; Cook et al., 19"91; Perry et al.,
1993), and clinical tnials of BSO in combination with
alkylating agent chemotherapy are under way (Bailey et al.,
1994).
In this paper the cytochemiucal staining technique described
by Larrauni et al. (I1987) has been modified to allow
quantification of nuclear and whole-cell GSH using
fluorescence image cytometry. The principle of the method is
that the sulphydryl-reactive dye mercury orange forms an
insoluble complex with GSH that precipitates on the slide.
As observed by Larrauri et al. (1987), this reaction appears
to be sufficiently rapid that it goes to completion within the
cell, since there was no visible diffusion of reaction product
into the surrounding region of the slide. Mercury orange also
reacts rapidly with cysteine 'tn aqueous solution, generating
an orange preqcipitate, and the method described here should
probably be considered an assay for non-protein sulphydryls
(NPSH), rather than GSH. However, estimates of cellular
cysteine generally give much lower values than those for
GSH (Jocelyn, 1972). The data shown in Figure 3 suggest
that mercury orange also reacts with protein sulphydryls
containing free SH groups. as shown by Reed (1990), but
because the reaction rate is slower than that with GSH.
background labelling of protein sulphydryls can be
miimised with careful control of the staining conditions.
The strong correlation with biochemically determined cellular
GSH content shown in Figure 4 confirms that the staining
technique used is fairly specific for GSH, although the y-
intercept suggests that it may become non-linear at low GSH
values owing to background labelling.
Compared with a standard biochemical assay for GSH. the
method descnrbed here offers a number of advantages. partic-
ularly for use with clinical samples. These include: (1) the
small sample size, making it suitable for fine-needle aspira-
tion biopsies; (2) the ability to distinguish between tumour
cells and stromal elements by their morphology. and to
measure cellular heterogeneity; (3) the fact that, in addition
to whole-cell GSH content, nuclear GSH can be obtained by
counterstaiing with a DNA-specific dye. Because of tech-
nical problems measuring nuclear GSH little is known about
its relevance to cytotoxic drug resistance, but potentially this
could play a more important role in protecting against the
effects of DNA-damaging agents than does the level of GSH
in cytoplasm. The compartmentalisation of GSH into a dis-
tinct nuclear pool has been suggested by in vitro experiments
showing differential responses of cytosolic and nuclear GSH
to BSO treatment (Edgren & Revesz, 1987; Britten et al..
1991; Jevtovic-Todorovic and Guenthner, 1992). The
existence for a distinct pool of nuclear GSH is strengthened
by our observation that. whereas the GSH-reactive agents
NEM and DEM deplete mercury orange fluorescence in the
nucleus and cytoplasm to a similar extent. inhibition of GSH
synthesis by BSO has a considerably greater effect on the
cytoplasm. Alternatively, it is possible that depletion of GSH
by BSO treatment is accompanied by an accumulation of
cysteine in the nucleus, since mercury orange also reacts with
cysteine. This has potentially important implications for the
use of BSO as an adjunct to cancer chemotherapy or
radiotherapy, because cysteine is predicted to be more
efficient than GSH in the repair of DNA radicals.
Experiments are under way to determine the relative impor-
tance of nuclear and cytoplasmic GSH in predicting response
to chemotherapy and radiation in cells lines pretreated with
different GSH-depleting agents and by prospectively compar-
ing results with clinical outcome in cancer patients.
Abbreviations
GSH. glutathione: NPSH. non-protein sulphydryl; FBS. fetal bovine
serum: x-MEM, m-minimum essential medium. DAPI, 4-6-diami-
dino-2-phenylindole; NEM. V-ethylmaleimide: DEM. diethylmaleate:
BSO. DL-buthionine-S.R-sulphoximine.
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